Literature DB >> 8046325

Recognition of major histocompatibility complex class I antigens by natural killer cells.

G Trinchieri1.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8046325      PMCID： PMC2191593          DOI： 10.1084/jem.180.2.417

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


× No keyword cloud information.
  23 in total

Review 1.  Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1992-10

Review 2.  Human natural killer cells: origin, clonality, specificity, and receptors.

Authors:  L Moretta; E Ciccone; M C Mingari; R Biassoni; A Moretta
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

Review 3.  The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex.

Authors:  W M Yokoyama; W E Seaman
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

4.  Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events.

Authors:  J Ruppert; J Alexander; K Snoke; M Coggeshall; E Herbert; D McKenzie; H M Grey; A Sette
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

5.  MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.

Authors:  D S Kaufman; R A Schoon; P J Leibson
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

6.  Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells.

Authors:  D S Kaufman; R A Schoon; P J Leibson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

7.  Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.

Authors:  V Litwin; J Gumperz; P Parham; J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

8.  Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes.

Authors:  F T Christiansen; C S Witt; E Ciccone; D Townend; D Pende; D Viale; L J Abraham; R L Dawkins; L Moretta
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

9.  P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.

Authors:  A Moretta; M Vitale; C Bottino; A M Orengo; L Morelli; R Augugliaro; M Barbaresi; E Ciccone; L Moretta
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

10.  Regulation of hematopoiesis in vitro by alloreactive natural killer cell clones.

Authors:  G Bellone; N M Valiante; O Viale; E Ciccone; L Moretta; G Trinchieri
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307
View more
  14 in total

1.  On the cell biology of pit cells, the liver-specific NK cells.

Authors:  Dian-Zhong Luo; David Vermijlen; Bulent Ahishali; Vasilis Triantis; Georgia Plakoutsi; Filip Braet; Karin Vanderkerken; Eddie Wisse
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones.

Authors:  M Vitale; S Sivori; D Pende; R Augugliaro; C Di Donato; A Amoroso; M Malnati; C Bottino; L Moretta; A Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

3.  Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I.

Authors:  D S Kaufman; R A Schoon; M J Robertson; P J Leibson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

Review 4.  Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells.

Authors:  R R Brutkiewicz; R M Welsh
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

5.  Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells.

Authors:  C H Tay; R M Welsh
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Natural killing activity in patients with spontaneous regression of malignant lymphoma.

Authors:  K Ono; M Kikuchi; N Funai; M Matsuzaki; Y Shimamoto
Journal:  J Clin Immunol       Date:  1996-11       Impact factor: 8.317

7.  Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission.

Authors:  Carey Farquhar; Sarah Rowland-Jones; Dorothy Mbori-Ngacha; Mary Redman; Barbara Lohman; Jennifer Slyker; Phelgona Otieno; Elizabeth Obimbo; Timothy Rostron; James Ochieng; Julius Oyugi; Rose Bosire; Grace John-Stewart
Journal:  AIDS Res Hum Retroviruses       Date:  2004-07       Impact factor: 2.205

8.  Normal development and function of natural killer cells in CD3 epsilon delta 5/delta 5 mutant mice.

Authors:  V Renard; L Ardouin; M Malissen; G Milon; M Lebastard; A Gillet; B Malissen; E Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.

Authors:  C S Falk; A Steinle; D J Schendel
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

10.  Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA.

Authors:  J A McCutcheon; J Gumperz; K D Smith; C T Lutz; P Parham
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.